The effect of the combined use of myo-inositol, vitamin D and selenium on the cytokine status in women of reproductive age with autoimmune thyroiditis

N. Pasyechko, V. Kulchinska, Kulchinska Veronika Mykolaiivna
{"title":"The effect of the combined use of myo-inositol, vitamin D and selenium on the cytokine status in women of reproductive age with autoimmune thyroiditis","authors":"N. Pasyechko, V. Kulchinska, Kulchinska Veronika Mykolaiivna","doi":"10.22141/2224-0721.19.3.2023.1270","DOIUrl":null,"url":null,"abstract":"Background. In recent years, in Ukraine and other countries of the world, there has been an increase in the frequency of autoimmune thyropathies. A significant role in the pathogenesis of autoimmune thyroiditis (AIT) is played by cytokines whose production is increased significantly during immunopathological reactions. The purpose of study was to investigate the effect of the combined use of myo-inositol, vitamin D and selenium on the cytokine status of women with euthyroidism, subclinical hypothyroidism and overt hypothyroidism against the background of autoimmune thyroiditis. Materials and methods. One hundred and forty-seven women aged 18–43 with AIT and 30 women of the control group were under observation. Patients of first group (n = 74) received myo-inositol at a dose of 2000 mg/day, cholecalciferol 2000 IU/day, and selenium 100 μg/day additionally to the main treatment. Patients of the second group (n = 73) received only cholecalciferol at a dose of 2000 IU/day and selenium 100 μg/day additionally to the main treatment. The functional state of the thyroid gland was studied by determining the levels of thyroid-stimulating hormone, free thyroxine, free triiodothyronine, antibodies to thyroid peroxidase (Ab-TPO) and antibodies to thyroglobulin (Ab-TG). The state of the systemic and local inflammatory process was evaluated according to parameters of tumor necrosis factor α, interleukins 6, 10, 17, and 23. Results. It should be noted all patients with AIT had changes in cytokine status, with some differences depending on the clinical variant of autoimmune thyroid disease. After three months of treatment of patients of the first group with myo-inositol at a dose of 2000 mg/day, cholecalciferol 2000 IU/day and selenium 100 μg/day, and patients of the second group only with cholecalciferol at a dose of 2000 IU/day and selenium at 100 μg /day, a significant difference was found between the indicators in both studied cohorts. Conclusions. The administration of myo-inositol, vitamin D, and selenium had a combination effect on the reduction of cytokine indicators, Ab-TPO and Ab-TG levels, which contributed to the compensation of the underlying disease.","PeriodicalId":13962,"journal":{"name":"INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22141/2224-0721.19.3.2023.1270","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background. In recent years, in Ukraine and other countries of the world, there has been an increase in the frequency of autoimmune thyropathies. A significant role in the pathogenesis of autoimmune thyroiditis (AIT) is played by cytokines whose production is increased significantly during immunopathological reactions. The purpose of study was to investigate the effect of the combined use of myo-inositol, vitamin D and selenium on the cytokine status of women with euthyroidism, subclinical hypothyroidism and overt hypothyroidism against the background of autoimmune thyroiditis. Materials and methods. One hundred and forty-seven women aged 18–43 with AIT and 30 women of the control group were under observation. Patients of first group (n = 74) received myo-inositol at a dose of 2000 mg/day, cholecalciferol 2000 IU/day, and selenium 100 μg/day additionally to the main treatment. Patients of the second group (n = 73) received only cholecalciferol at a dose of 2000 IU/day and selenium 100 μg/day additionally to the main treatment. The functional state of the thyroid gland was studied by determining the levels of thyroid-stimulating hormone, free thyroxine, free triiodothyronine, antibodies to thyroid peroxidase (Ab-TPO) and antibodies to thyroglobulin (Ab-TG). The state of the systemic and local inflammatory process was evaluated according to parameters of tumor necrosis factor α, interleukins 6, 10, 17, and 23. Results. It should be noted all patients with AIT had changes in cytokine status, with some differences depending on the clinical variant of autoimmune thyroid disease. After three months of treatment of patients of the first group with myo-inositol at a dose of 2000 mg/day, cholecalciferol 2000 IU/day and selenium 100 μg/day, and patients of the second group only with cholecalciferol at a dose of 2000 IU/day and selenium at 100 μg /day, a significant difference was found between the indicators in both studied cohorts. Conclusions. The administration of myo-inositol, vitamin D, and selenium had a combination effect on the reduction of cytokine indicators, Ab-TPO and Ab-TG levels, which contributed to the compensation of the underlying disease.
肌醇、维生素D和硒联合使用对自身免疫性甲状腺炎育龄妇女细胞因子状态的影响
背景。近年来,在乌克兰和世界其他国家,自身免疫性甲状腺疾病的发病率有所增加。在自身免疫性甲状腺炎(AIT)的发病机制中,细胞因子的产生在免疫病理反应中显著增加。本研究的目的是探讨肌醇、维生素D和硒联合使用对自身免疫性甲状腺炎背景下甲状腺功能亢进、亚临床甲状腺功能减退和明显甲状腺功能减退妇女细胞因子状态的影响。材料和方法。147名年龄在18-43岁的AIT患者和30名对照组的女性接受了观察。第一组(74例)患者在主治疗的基础上加用肌醇2000 mg/d、胆骨化醇2000 IU/d、硒100 μg/d。第二组患者(n = 73)在主要治疗的基础上仅给予2000 IU/d的胆骨化醇和100 μg/d的硒。通过测定促甲状腺激素、游离甲状腺素、游离三碘甲状腺原氨酸、甲状腺过氧化物酶抗体(Ab-TPO)和甲状腺球蛋白抗体(Ab-TG)水平来研究甲状腺功能状态。根据肿瘤坏死因子α、白细胞介素6、10、17和23的参数评估全身和局部炎症过程的状态。结果。值得注意的是,所有AIT患者的细胞因子状态都发生了变化,根据自身免疫性甲状腺疾病的临床变异有一定的差异。第一组患者服用2000毫克/天的肌醇、2000 IU/天的胆骨化醇和100 μg/天的硒,第二组患者只服用2000 IU/天的胆骨化醇和100 μg/天的硒,治疗三个月后,两个研究队列的指标有显著差异。结论。肌醇、维生素D和硒的施用对细胞因子指标、Ab-TPO和Ab-TG水平的降低具有联合作用,这有助于对潜在疾病的补偿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信